Research is exploring the role of transposable elements in leukemic stem cells, with studies suggesting they may influence stemness in both normal and leukemic hematopoiesis. The regulation of these elements, including through mechanisms such as histone methyltransferase and piRNAs, is being investigated for its potential to combat cancer and drug resistance. Findings indicate that targeting these elements and related pathways may offer a therapeutic approach to eliminating malignant stem cells in certain types of leukemia.